Politics & Policy By Steve Usdin
Contributing Editor

ROCKVILLE, Md. - Scientific controversy over the risks and benefits of a live attenuated AIDS vaccine came into public view last week, with top NIH officials accusing AIDS physicians who are pushing for human trials of a vaccine of minimizing the dangers and significantly underestimating the amount of work needed before a Phase I trial can begin.